The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
 
Marye Boers-Sonderen
No Relationships to Disclose
 
Stijn Muselaers
No Relationships to Disclose
 
Tim van Oostenbrugge
Travel, Accommodations, Expenses - Astellas Pharma
 
Otto Boerman
No Relationships to Disclose
 
Ingrid Desar
No Relationships to Disclose
 
Alexander Stillebroer
No Relationships to Disclose
 
Sasja Mulder
No Relationships to Disclose
 
Carla M.L.- Van Herpen
No Relationships to Disclose
 
Hans Langenhuijsen
No Relationships to Disclose
 
Egbert Oosterwijk
No Relationships to Disclose
 
Wim J.G. Oyen
No Relationships to Disclose
 
Peter Mulders
No Relationships to Disclose